How we helped a mid-size Pharma delve into the competitor landscape and support its brand strategy development.
The challenge: Βuilding an up-to-date biosimilar competitor landscape. A…
Biosimilars on the rise: they are just getting started
Biologics have revolutionized the management of previously intractable…
Biosimilars: Enhancing physician uptake in the EU
At the moment, EU physicians seem much more comfortable than their US…
The curious case of biosimilar launches in the US
The Biologics Price Competition and Innovation Act (BPCI Act) of 2009 provided…